Published papers and abstracts

Reference	Options
Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C. Measures of effect: Relative risks, odds ratios, risk difference, and 'number needed to treat'. Kidney Int 2007; Jul 25.
Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW. The valuable contribution of observational studies to nephrology. Kidney Int 2007; Jun 27.
Stel VS, Jager KJ, Zoccali C, Wanner C, Dekker FW. The randomized clinical trial: An unbeatable standard in clinical research? Kidney Int 2007; Jun 27.
Jager KJ, Zoccali C, Kramar R, Dekker FW. Measuring disease occurrence. Kidney Int 2007; Jun 20.
Jager KJ, Zoccali C. Clinical Databases and the QUEST Initiative. Blood Purif 2007;25:219-220.
Jager KJ, van Dijk PC. Has the rise in the incidence of renal replacement therapy in developed countries come to an end? Nephrol Dial Transplant 2007;22:678-680.
van Dijk PCW, Zwinderman AH, Dekker FW, Schön S, Stel VS, Finne P, Jager KJ. Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int 2007;71:53-59.
van Manen JG, van Dijk PCW, Stel VS, Dekker FW, Clèries M, Conte F, Feest T, Kramar R, Leivestad T, Briggs JD, Stengel B, Jager KJ. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007;22:187-195.
Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Løkkegaard H, Lopot F, Jin DC, International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 2006;17:3510-3519.
The ESRD Incidence Study Group: Stewart JH, McCredie MRE, Williams SM, Trpeski L, Fenton SS, McDonald SP, Jager KJ, van Dijk PCW, Finne P, Schon S, Leivestad T, Løkkegaard H, Billiouw JM, Kramar R, Magaz A, Vela E. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002. Diabet Med 2006;23:1364-1369.
The ESRD Incidence Study Group: Stewart JH, McCredie MRE, Williams SM, Fenton SS, Trpeski L, McDonald SP, Jager KJ, van Dijk PCW, Finne P, Schon S, Leivestad T, Løkkegaard H, Billiouw JM, Kramar R, Magaz A, Vela E, Garcia-Blasco MJ, Ioannidis GA, Lim The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002. Am J Kidney Dis 2006;48:183-191.
The ESRD Incidence Study Group: Stewart JH, McCredie MRE, Williams SM, Fenton SS, Trpeski L, McDonald SP, Jager KJ, van Dijk PCW, Finne P, Schon S, Leivestad T, Løkkegaard H, Billiouw JM, Kramar R, Magaz A, Cleries M, Garcia-Blasco MJ, Ioannidis GA, Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant 2006;21:2178-2183.
Geddes CC, van Dijk PCW, McArthur S, Metcalfe W, Jager KJ, Zwinderman AH, Mooney M, Fox JG, Simpson K. The ERA-EDTA cohort study--comparison of methods to predict survival on renal replacement therapy. Nephrol Dial Transplant 2006;21:945-956.
Lameire N, Jager KJ, Van Biesen W, de Bacquer D, Vanholder R. Chronic kidney disease: A European perspective. Kidney Int 2005;68(99):S30-S38.
Stel VS, van Dijk PCW, van Manen JG, Dekker FW, Ansell D, Conte F, Kramar R, Leivestad T, Vela E, Briggs JD, Jager KJ. Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant 2005;20:2803-2811.
Jager KJ, Zoccali C. QUality European STudies (QUEST) - a step forward in the quality of RRT care. Nephrol Dial Transplant 2005;20:2005-2006.
van Dijk PCW, Jager KJ, Stengel B, Grönhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005;67(4):1489-1499.
Stel VS, van Dijk PCW, Dekker FW, Conte F, Feest T, Leivestad T, Kramar R, Vela E, Briggs JD, Jager KJ. Co-morbidity and Access to Renal Transplantation within Europe: an ERA-EDTA Registry Study. J Am Soc Nephrol, 2004;15:396A (abstract).
van Dijk PCW, Jager KJ, Stel VS, Zwinderman AH. Mortality in the general population (GP) and its relationship with RRT. J Am Soc Nephrol, 2004;15:385A (abstract).
van der Heijden BJ, van Dijk PCW, Verrier-Jones K, Jager KJ, Briggs JD. Renal replacement therapy in children: data from 12 registries in Europe. Pediatr Nephrol 2004; 19:213-221.
van Manen JG, van Dijk PCW, Dekker FW, Conte F, Feest T, Leivestad T, Kramar R, Vela E, Briggs JD, Jager KJ. How important is adjustment for co-morbidity in the international comparison of survival in RRT patients. J Am Soc Nephrol 2003;14:829A (abstract).
Fox JG, Geddes CC, Simpson K, Metcalfe W, Jager KJ, Zwinderman AH et al. European survey to predict survival on renal replacement therapy - Comparison of a simple scoring system with a regression model. J Am Soc Nephrol 2003;14:251A (abstract).
Jager KJ, van Dijk PCW, Dekker FW, Stengel B, Simpson K, Briggs JD. The epidemic of aging in renal replacement therapy: an update on. elderly patients and their outcomes Clin Nephrol 2003;60:352-360.
Stengel B, Billon S, van Dijk PCW, Jager KJ, Dekker FW, Simpson K, Briggs JD. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 2003;18:1824-1833.
van Dijk PCW, Jager KJ, Briggs JD, Zwinderman AH. Modeling time to death for patients on Renal Replacement Therapy. Controlled Clinical Trials 2003;24:127S (abstract).
van der Heijden AJ, van Dijk PCW, Verrier-Jones K, Jager KJ, Briggs JD. Renal replacement therapy in Europe: data over 20 years in children collected by the ERA-EDTA registry from 12 national or regional registries. J Am Soc Nephrol 2002;13:599A (abstract).
Jager KJ, van Dijk PCW, Dekker FW, Stengel B, Simpson K, Briggs JD. The epidemic of aging in RRT: an update on elderly and their outcome. J Am Soc Nephrol 2002;13:399A (abstract).
Stengel B, Bruno L, Jager KJ, van Dijk PCW, Dekker FW, Simpson K, Briggs JD. Incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-99. J Am Soc Nephrol 2002;13:599A (abstract).
van Dijk PCW, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Grönhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001;16:1120-1129.
Briggs JD, Jager K. The first year of the new ERA-EDTA registry. Nephrol Dial Transplant 2001;16:1130-1131.
Jager KJ, van Dijk PCW, Grönhagen-Riska C, Dekker FW, Feest T, Briggs JD. Incidence and outcome of treated diabetic ESRD in the new ERA-EDTA registry. J Am Soc Nephrol 2001;12:897A (abstract).
Jager KJ, van Dijk PCW, Tsakiris D, Dekker FW, Briggs JD. Trends in incidence and outcome of patients starting RRT for multiple myeloma in the new ERA-EDTA registry. J Am Soc Nephrol 2001;12:332A (abstract).
Jager KJ, van Dijk PCW, Dekker FW, Cornet R, Krediet RT, Briggs JD. The European registry: where do we stand? Perit Dial Int 2000;20 Suppl 2:S118-120.